View in EDS

Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients.

Saved in:
Bibliographic Details
Title: Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients.
Authors: Epling BP; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Powers JH 3rd; Clinical Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 Aug 16; Vol. 66 (8), pp. e0076622. Date of Electronic Publication: 2022 Jul 18.
Publication Type: Letter; Comment
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35862749
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Epling+BP%22">Epling BP</searchLink>; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Powers+JH+3rd%22">Powers JH 3rd</searchLink>; Clinical Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220315061%22">Antimicrobial agents and chemotherapy</searchLink> [Antimicrob Agents Chemother] 2022 Aug 16; Vol. 66 (8), pp. e0076622. <i>Date of Electronic Publication: </i>2022 Jul 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Microbiology%22">American Society for Microbiology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0315061 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1098-6596 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200664804%22">00664804 </searchLink><i>NLM ISO Abbreviation: </i>Antimicrob Agents Chemother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35862749
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1128/aac.00766-22
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0076622
    Titles:
      – TitleFull: Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Epling BP
      – PersonEntity:
          Name:
            NameFull: Powers JH 3rd
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 08
              Text: 2022 Aug 16
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1098-6596
          Numbering:
            – Type: volume
              Value: 66
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Antimicrobial agents and chemotherapy
              Type: main
ResultId 1